As tumors lose expression of mir-34, through promoter methylation or the loss of p53, the expression and function of NR4A2 may become enhanced, shifting the balance from tumor suppression to tumor progression (Fig. 7), though this may not be directly traceable because of the complexity of miRNA-mRNA regulatory networks. The gene discussed is NR4A2; the disease is neoplasm.